An investigation for investors in Ionis Pharmaceuticals Inc (NASDAQ:IONS) shares over potential securities laws violations by Ionis Pharmaceuticals Inc was announced and NASDAQ:IONS stockholders should contact the Shareholders Foundation.

San Diego, CA -- (SBWire) -- 03/14/2017 --An investigation was announced for investors in Ionis Pharmaceuticals Inc (NASDAQ:IONS) shares over potential securities laws violations by Ionis Pharmaceuticals Inc in connection certain financial statements.

Investors who purchased shares of Ionis Pharmaceuticals Inc (NASDAQ:IONS) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call 858-779-1554.

The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of Ionis Pharmaceuticals Inc (NASDAQ:IONS) concerning whether a series of statements by Ionis Pharmaceuticals Inc regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

Ionis Pharmaceuticals, Inc., formerly Isis Pharmaceuticals, Inc., is engaged in discovering and developing ribonucleic acid-targeted (RNA-targeted) therapeutics.

On March 6, 2017, Ionis Pharmaceuticals Inc's subsidiary Akcea Therapeutics revealed data from a Phase 3 study of volanesorsen, its experimental therapy for familial chylomicronemia syndrome. Akcea Therapeutics announced that 10 of the 66 patients that were involved in the study have discontinued treatment. Half of the patients who discontinued the therapy cited injection site reactions, and the other half discontinued due to platelet declines. Ionis Pharmaceuticals Inc reported 8 serious adverse events associated with volanesorsen.

Shares of Ionis Pharmaceuticals Inc (NASDAQ:IONS) declined on March 10, 2017 to as low as $39.85 per share.

Those who purchased shares of Ionis Pharmaceuticals Inc have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com